Enhancer provides a potential target for "undruggable" MYC in pediatric medulloblastoma
April 22, 2026
April 22, 2026
MEMPHIS, Tennessee, April 22 [Category: BizHospital] -- St. Jude Children's Research Hospital issued the following news release:
* * *
Enhancer provides a potential target for "undruggable" MYC in pediatric medulloblastoma
*
Efforts to develop effective therapies for MYC -amplified Group 3 medulloblastoma (G3-MB) are hindered by an incomplete understanding of how MYC expression is controlled in these tumors. MYC has long been con . . .
* * *
Enhancer provides a potential target for "undruggable" MYC in pediatric medulloblastoma
*
Efforts to develop effective therapies for MYC -amplified Group 3 medulloblastoma (G3-MB) are hindered by an incomplete understanding of how MYC expression is controlled in these tumors. MYC has long been con . . .